innovationNewsغير مصنف

Samsung Biologics to issue new shares worth $1.1 billion ahead of IPO

SEOUL (Reuters) – South Korean drugmaker Samsung Biologics Co plans to issue about 1.23 trillion won ($1.12 billion) of new shares as it lines up an initial public offering, its biggest shareholder…

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى